Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A PSC-tailored deep learning model for liver segmentation on fat-saturated T2-weighted MR: Robustness to hepatic dysmorphia and multicentre generalisability.

European journal of radiology·2026

Same author

Does Casting Material Influence the Number of Casts Required Before Achilles Tenotomy in the Ponseti Treatment of Severe Idiopathic Clubfoot?

Journal of clinical medicine·2026

Same author

Definition, diagnosis, and treatment of primary biliary cholangitis - autoimmune hepatitis (PBC-AIH) variant: An international expert delphi consensus.

Hepatology (Baltimore, Md.)·2026

Same author

Beyond the Graft: Optimizing Post-Transplant Care in Primary Sclerosing Cholangitis.

Journal of clinical medicine·2026

Same author

Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitis.

JHEP reports : innovation in hepatology·2026

Same author

The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view.

Nature reviews. Gastroenterology & hepatology·2026

Search research articles

Related Experiment Video

Updated: Aug 24, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Prognostic Scoring Systems in Primary Biliary Cholangitis: An Update.

Miki Scaravaglio¹, Marco Carbone¹

¹Division of Gastroenterology and Hepatology, Department of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza (MB), Italy.

Clinics in Liver Disease

|October 21, 2022

Summary

Primary biliary cholangitis (PBC) risk can be predicted early using prognostic models. This review explores existing and new systems, including omics biomarkers, for personalized PBC medicine.

Keywords:

Autoimmune liver disease Prediction Primary biliary cholangitis Prognostic models Risk-stratification

More Related Videos

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

Related Experiment Videos

Last Updated: Aug 24, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

Area of Science:

Hepatology
Internal Medicine
Clinical Prediction Models

Background:

Primary biliary cholangitis (PBC) is a chronic liver disease with variable progression and treatment response.
Current prognostic models aid in risk stratification and management but lack early prediction capabilities.
Timely risk stratification is crucial for optimal therapeutic strategies, especially with emerging disease-modifying drugs.

Purpose of the Study:

To review established and novel prognostic systems for Primary Biliary Cholangitis (PBC).
To discuss the potential of omics-derived biomarkers in PBC risk prediction.
To explore the implementation of personalized medicine in PBC management.

Main Methods:

Literature review of prognostic models in PBC.
Analysis of existing risk stratification tools.
Exploration of omics technologies for biomarker discovery.

Main Results:

Several prognostic models exist, improving risk stratification but often applied later in disease course.
Early prediction of outcomes at PBC onset remains a challenge for clinical implementation.
Omics biomarkers show promise for enhancing predictive accuracy.

Conclusions:

Established and novel prognostic systems are vital for managing PBC.
Early risk stratification using advanced models and omics biomarkers can facilitate personalized medicine.
Integrating these approaches promises improved patient outcomes in PBC.